The level of protection achieved by the standard two doses of COVID-19 mRNA vaccines in
patients receiving maintenance hemodialysis (MHD) remains unclear. To study this we used …

On 1 October 2019, a locally-acquired Zika virus disease case was laboratory confirmed in
Hyères, Var department. Active case finding identified two additional locally-acquired cases …

The description of protective humoral and T cell immune responses specific against SARS‐CoV‐2
has been reported among immunocompetent (IC) individuals developing COVID‐19 …

Transplant recipients, who receive therapeutic immunosuppression to prevent graft rejection,
are characterized by high coronavirus disease 2019 (COVID-19)–related mortality and …

Patients on maintenance hemodialysis (MHD), which are at high risk of infection by SARS-CoV-2
virus and death due to COVID-19, have been prioritized for vaccination. However, …

Kidney transplant recipients (KTRs) have reduced ability to mount adequate antibody response
after two doses of the COVID-19 mRNA vaccine. French health authorities have allowed …

Background Patients on maintenance hemodialysis (MHD) are at high risk of infection with
SARS-Cov-2 and death due to COVID-19. This vulnerable population has been prioritized for …

Transplant recipients, which receive therapeutic immunosuppression to prevent graft rejection,
are characterized by high COVID-19-related mortality and defective response to vaccines…

Patients on maintenance hemodialysis (MHD) are at high risk of both infection by SARS-CoV-2
and death from COVID-19, 1 justifying the early prioritization of this vulnerable population …

Only a minority of kidney transplant recipients (KTRs) develop protective neutralizing titers
of anti-receptor binding domain of spike protein (RBD) IgG after two doses of mRNA COVID-…